BACKGROUND: Marburg virus (MARV) is an emerging zoonotic pathogen that causes hemorrhagic fever. MARV VP24 (mVP24) protein interacts with the host cell protein Kelch-like-ECH-associated protein 1 (Keap1). Keap1 interacts with and promotes the degradation of IκB kinase β (IKKβ), a component of the IκB kinase (IKK) complex that regulates nuclear factor-κB (NF-κB) activity. We studied whether mVP24 could relieve Keap1 repression of the NF-κB pathway. METHODS: Coimmunoprecipitation assays were used to examine the interaction between Keap1 and IKKβ in the presence of wild-type mVP24 and mutants of mVP24 defective for binding to Keap1. Western blotting was used to determine levels of IKKβ expression in the presence of Keap1 and mVP24. NF-κB promoter-luciferase assays were used to determine the effect of mVP24 on Keap1-induced repression of activity. RESULTS: Expression of wild-type mVP24 disrupted the interaction of IKKβ and Keap1, whereas weakly interacting and noninteracting mVP24 mutants did not disrupt the interaction between Keap1 and IKKβ. The interaction of mVP24 with Keap1 enhanced IKKβ levels in the presence of Keap1. The interaction of mVP24 with Keap1 also relieved Keap1 repression of NF-κB reporter activity. CONCLUSIONS: mVP24 can relieve Keap1 repression of the NF-κB pathway through its interaction with Keap1.
BACKGROUND: Marburg virus (MARV) is an emerging zoonotic pathogen that causes hemorrhagic fever. MARV VP24 (mVP24) protein interacts with the host cell protein Kelch-like-ECH-associated protein 1 (Keap1). Keap1 interacts with and promotes the degradation of IκB kinase β (IKKβ), a component of the IκB kinase (IKK) complex that regulates nuclear factor-κB (NF-κB) activity. We studied whether mVP24 could relieve Keap1 repression of the NF-κB pathway. METHODS: Coimmunoprecipitation assays were used to examine the interaction between Keap1 and IKKβ in the presence of wild-type mVP24 and mutants of mVP24 defective for binding to Keap1. Western blotting was used to determine levels of IKKβ expression in the presence of Keap1 and mVP24. NF-κB promoter-luciferase assays were used to determine the effect of mVP24 on Keap1-induced repression of activity. RESULTS: Expression of wild-type mVP24 disrupted the interaction of IKKβ and Keap1, whereas weakly interacting and noninteracting mVP24 mutants did not disrupt the interaction between Keap1 and IKKβ. The interaction of mVP24 with Keap1 enhanced IKKβ levels in the presence of Keap1. The interaction of mVP24 with Keap1 also relieved Keap1 repression of NF-κB reporter activity. CONCLUSIONS: mVP24 can relieve Keap1 repression of the NF-κB pathway through its interaction with Keap1.
Authors: Wei Xu; Megan R Edwards; Dominika M Borek; Alicia R Feagins; Anuradha Mittal; Joshua B Alinger; Kayla N Berry; Benjamin Yen; Jennifer Hamilton; Tom J Brett; Rohit V Pappu; Daisy W Leung; Christopher F Basler; Gaya K Amarasinghe Journal: Cell Host Microbe Date: 2014-08-13 Impact factor: 21.023
Authors: St Patrick Reid; Lawrence W Leung; Amy L Hartman; Osvaldo Martinez; Megan L Shaw; Caroline Carbonnelle; Viktor E Volchkov; Stuart T Nichol; Christopher F Basler Journal: J Virol Date: 2006-06 Impact factor: 5.103
Authors: Megan R Edwards; Gai Liu; Chad E Mire; Suhas Sureshchandra; Priya Luthra; Benjamin Yen; Reed S Shabman; Daisy W Leung; Ilhem Messaoudi; Thomas W Geisbert; Gaya K Amarasinghe; Christopher F Basler Journal: Cell Rep Date: 2016-02-11 Impact factor: 9.423
Authors: Judith Olejnik; Adam J Hume; Daisy W Leung; Gaya K Amarasinghe; Christopher F Basler; Elke Mühlberger Journal: Curr Top Microbiol Immunol Date: 2017 Impact factor: 4.291
Authors: Britney Johnson; Jing Li; Jagat Adhikari; Megan R Edwards; Hao Zhang; Toni Schwarz; Daisy W Leung; Christopher F Basler; Michael L Gross; Gaya K Amarasinghe Journal: J Mol Biol Date: 2016-08-04 Impact factor: 5.469
Authors: Megan R Edwards; Gai Liu; Sampriti De; Julien Sourimant; Colette Pietzsch; Britney Johnson; Gaya K Amarasinghe; Daisy W Leung; Alexander Bukreyev; Richard K Plemper; Zachary Aron; Terry L Bowlin; Donald T Moir; Christopher F Basler Journal: ACS Infect Dis Date: 2020-01-15 Impact factor: 5.084